These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6217328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis.
    Ghishan FK, LaBrecque DR, Younoszai K.
    J Pediatr; 1978 Dec; 93(6):1042-3. PubMed ID: 102752
    [No Abstract] [Full Text] [Related]

  • 5. The hazards of gold injections in children with juvenile rheumatoid arthritis: comment on the article by Lehman.
    Jacobs JC.
    Arthritis Rheum; 1993 Nov; 36(11):1636-7. PubMed ID: 8240444
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B, Veneziani M, Bellelli A, Portioli I.
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic toxicity associated with gold therapy.
    Favreau M, Tannenbaum H, Lough J.
    Ann Intern Med; 1977 Dec; 87(6):717-9. PubMed ID: 412451
    [Abstract] [Full Text] [Related]

  • 10. Hepatonecrosis resulting from parenteral gold therapy in pemphigus vulgaris.
    Rye B, Krusinski PA.
    J Am Acad Dermatol; 1993 Jan; 28(1):99-101. PubMed ID: 8425980
    [Abstract] [Full Text] [Related]

  • 11. [Chrysotherapy induced hepatic damage].
    Schapira D, Nahir AM.
    Harefuah; 1986 Jan 01; 110(1):14-5. PubMed ID: 3082727
    [No Abstract] [Full Text] [Related]

  • 12. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E.
    Med Clin (Barc); 1985 Jun 08; 85(2):73-9. PubMed ID: 3160899
    [No Abstract] [Full Text] [Related]

  • 13. Fatal hepatic necrosis associated with parenteral gold therapy.
    Watkins PB, Schade R, Mills AS, Carithers RL, Van Thiel DH.
    Dig Dis Sci; 1988 Aug 08; 33(8):1025-9. PubMed ID: 3134176
    [Abstract] [Full Text] [Related]

  • 14. Gold therapy in rheumatoid arthritis.
    Schorn D, Anderson IF.
    S Afr Med J; 1975 Aug 30; 49(37):1505-6. PubMed ID: 125934
    [Abstract] [Full Text] [Related]

  • 15. [Deaths from gold therapy in Denmark during 1960-64].
    Iuel J.
    Ugeskr Laeger; 1973 Jul 30; 135(31):1639-42. PubMed ID: 4271249
    [No Abstract] [Full Text] [Related]

  • 16. Gold nephropathy in juvenile rheumatoid arthritis.
    Husserl FE, Shuler SE.
    Am J Dis Child; 1979 Jan 30; 133(1):50-2. PubMed ID: 104619
    [Abstract] [Full Text] [Related]

  • 17. Gold and liver biopsy.
    Prichanond S, Skosey JL.
    Ann Intern Med; 1978 Apr 30; 88(4):579. PubMed ID: 416737
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis and neutropenia secondary to gold thiomalate therapy for rheumatoid arthritis.
    Smith MD.
    Aust N Z J Med; 1986 Feb 30; 16(1):72-4. PubMed ID: 3085648
    [Abstract] [Full Text] [Related]

  • 19. Neutropenia associated with chrysotherapy for juvenile rheumatoid arthritis.
    Thompson DM, Pegelow CH, Singsen BH, Powars DR, Hanson V.
    J Pediatr; 1978 Nov 30; 93(5):871-5. PubMed ID: 101649
    [Abstract] [Full Text] [Related]

  • 20. [Toxic effects of the second dose of sodium aurothiomalate in childhood systemic chronic arthritis].
    Bustabad Reyes S, González García T, Trujillo Martín E, Gantes Mora M, Rodríguez-Lozano B.
    An Esp Pediatr; 1997 Apr 30; 46(4):391-3. PubMed ID: 9214235
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.